Stay updated on Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-20T05:22:48.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-22T11:27:23.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision badge updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-08T01:44:01.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Minor site revision update to v3.4.2 from v3.4.1; no changes to study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T12:58:26.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1 and no longer displays Revision: v3.4.0.
    Difference
    0.1%
    Check dated 2026-02-07T07:18:45.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    A glossary toggle was added; QC-related metadata labels were updated to display 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', replacing the previous labels.
    Difference
    0.3%
    Check dated 2026-01-24T04:56:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Amurubicin Combo in Refractory SCLC Clinical Trial page.